Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-026474
Filing Date
2020-09-29
Accepted
2020-09-29 18:22:43
Documents
1
Period of Report
2020-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4015
  Complete submission text file 0000899243-20-026474.txt   5481
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Issuer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address
Rangwala Reshma (Reporting) CIK: 0001825322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36361 | Film No.: 201210052